A Wisconsin native, David N. Cornfield, MD, earned his medical degree from the University of Wisconsin School of Medicine in 1986. As Pediatric resident at Children’s Mercy Hospital in Kansas City, Missouri, Cornfield was named Most Outstanding House Officer and Chief Resident. Cornfield completed subspecialty training in pediatric pulmonology and critical care medicine at the University of Colorado in 1993. Cornfield then joined the University of Minnesota Medical School where he became Professor of Pediatrics, Physiology, and Surgery, Division Director of Pediatric Pulmonary and Critical Care Medicine, interim chair of Pediatrics (2003–2004), and Associate Dean for Research. In 2005, he joined Stanford University as the inaugural Bass Professor in Pediatric Pulmonary Medicine and director of the Center for Excellence in Pulmonary Biology and Chief of the Division of Pediatric Pulmonary, Asthma, and Sleep Medicine at Stanford and Lucile Packard Children’s Hospital. He led the Division of Pediatric Critical Care Medicine from 2006 to 2016. His research explores pulmonary vascular development, alveolarization, oxygen-sensing, pulmonary vascular tone, the perinatal pulmonary circulation and uterine contractility. His lab has been continuously NIH-funded since 1998. Translational work includes inhaled nitric oxide, acute lung injury, lung microbiome, asthma monitoring, non-invasive monitoring of organ rejection, and physician-scientist training. He has led an NIH pulmonary biology training grant since 2015. A past President of the Society for Pediatric Research, service includes regular membership on editorial boards (6), national and international peer review committees, and multiple committees for the AAP, ATS, AHA, and March of Dimes. Awards include the Daniel C. Darrow Award, Richard B. Rowe Award, AHA Established-Investigator and Clinician-Scientist Awards, and Clinician of the Year from the University of Minnesota, Moss Award (Stanford).  He founded and directs separate physician scientist training program for the Chan Zuckerberg Biohub and the Wu Tsai Human Performance Alliance.